myHIVteam

Yes, Egrifta SV (Tesamorelin) has been used to address hard belly (lipohypertrophy) in people living with HIV. Here are some key points:

- Mechanism: Egrifta is a growth hormone-releasing factor (GHRF) analog that helps metabolize hard belly fat
- Administration: It is generally injected subcutaneously once a day
- Side Show Full Answer

Yes, Egrifta SV (Tesamorelin) has been used to address hard belly (lipohypertrophy) in people living with HIV. Here are some key points:

- Mechanism: Egrifta is a growth hormone-releasing factor (GHRF) analog that helps metabolize hard belly fat.
- Administration: It is generally injected subcutaneously once a day.
- Side Effects: Common side effects include redness and itchiness at the injection site, swelling in the hands and feet, and muscle and joint pain. Rare but serious side effects include an increased risk of certain cancers, diabetes, and allergic reactions.

For more details, you can visit the Egrifta page on myHIVteam.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

HIV and Hard Belly: Lipodystrophy Pictures, Symptoms, and Treatment | myHIVteam

Egrifta (Tesamorelin) for HIV | myHIVteam